Kuwaki et al., 2012 - Google Patents
Orexin neurons and emotional stressKuwaki et al., 2012
- Document ID
- 14332363861729804435
- Author
- Kuwaki T
- Zhang W
- Publication year
- Publication venue
- Vitamins & hormones
External Links
Snippet
Stress increases cardiac function, ventilation, and body temperature and induces analgesia. These changes, which result in an increase in metabolic rate, oxygen supply, and the conduction velocity of nerve impulses, prepare the body for a fight-or-flight response. A part …
- 101710023151 HCRT 0 title abstract description 184
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dampney | Central neural control of the cardiovascular system: current perspectives | |
Nattie et al. | Central chemoreceptors: locations and functions | |
Nattie | Central chemosensitivity, sleep, and wakefulness | |
Kuwaki et al. | Orexin neurons and emotional stress | |
Roosevelt et al. | Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat | |
Herrera et al. | Sleep & metabolism: the multitasking ability of lateral hypothalamic inhibitory circuitries | |
Kayaba et al. | Attenuated defense response and low basal blood pressure in orexin knockout mice | |
Alkadhi et al. | Neurobiological consequences of sleep deprivation | |
Madden et al. | Hypoxic activation of arterial chemoreceptors inhibits sympathetic outflow to brown adipose tissue in rats | |
Carrive et al. | Orexin and central modulation of cardiovascular and respiratory function | |
Brown et al. | Control of sleep and wakefulness | |
Amann et al. | Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans | |
Zhang et al. | Orexin neuron-mediated skeletal muscle vasodilation and shift of baroreflex during defense response in mice | |
Kuwaki | Thermoregulation under pressure: a role for orexin neurons | |
Patwari et al. | Congenital central hypoventilation syndrome and the PHOX2B gene: a model of respiratory and autonomic dysregulation | |
Chen et al. | Spontaneous sleep in mice with targeted disruptions of neuronal or inducible nitric oxide synthase genes | |
Clark et al. | Feeding-elicited cataplexy in orexin knockout mice | |
Zhang et al. | Multiple components of the defense response depend on orexin: evidence from orexin knockout mice and orexin neuron-ablated mice | |
Kuwaki | Orexin (hypocretin) participates in central autonomic regulation during fight-or-flight response | |
Kuwaki et al. | Emotional and state-dependent modification of cardiorespiratory function: role of orexinergic neurons | |
Kuwaki et al. | Orexin neurons as arousal-associated modulators of central cardiorespiratory regulation | |
Sinton | Orexin/hypocretin plays a role in the response to physiological disequilibrium | |
Goulart et al. | NMDA receptors in the insular cortex modulate cardiovascular and autonomic but not neuroendocrine responses to restraint stress in rats | |
Moffitt et al. | Hindlimb unloading elicits anhedonia and sympathovagal imbalance | |
Jacobs et al. | Activity of brain serotonergic neurons in relation to physiology and behavior |